🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of the study are: * To evaluate the long-term safet...
Status
Completed
Location
Clinical Trial Site
Start Date
2018-03-13
Trial ID
NCT03409744
Treatments Being Tested
The primary objective of the study is to demonstrate the reduction of low-d...
Status
Completed
Location
Regeneron Research Site
Start Date
2018-01-18
Trial ID
NCT03399786
Treatments Being Tested
The primary objective of the study is to evaluate the reduction of LDL-C by...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2017-11-10
Trial ID
NCT03175367
Treatments Being Tested
This observational, multicenter, retrospective and prospective study aims t...
Status
Recruiting
Location
Unité de Lipidologie et Prévention Cardiovasculaire, Centre de Compétence Dyslipidémies Rares (CEDRA), Service de Nutrition, Hôpital Pitié-Salpétriêre
Start Date
2026-04-30
Trial ID
NCT07447648
The primary objective is to determine the change in Triglyceride (TG) level...
Status
Completed
Location
Regeneron Research Facility
Start Date
2018-06-07
Trial ID
NCT03452228
Treatments Being Tested
This is a phase 1, randomized, double-blind, placebo-controlled, multiple a...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02107872
This is an open-label, single-arm study to assess the reduction of low-dens...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-04
Trial ID
NCT02265952
Treatments Being Tested
Phase 1, first-in-human, randomized, ascending single-dose, placebo-control...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT01749878
The primary objective of the study is to determine the proportion of patien...
Status
Terminated
Location
Radin Cardivascular Medical Group, Inc
Start Date
2021-07-12
Trial ID
NCT04863014
Treatments Being Tested
Provide compassionate use of evinacumab...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06500598
Treatments Being Tested